As tests and screenings for chronic conditions improve, Connecticut residents will have better access after lawmakers passed legislation mandating health insurance plans cover biomarker tests starting ...
State lawmakers are looking at a new bill that would require Medicaid and private insurance providers to cover biomarker testing for cancer patients. Biomarker testing can identify what type of cancer ...
Cancer test maker Lucid Diagnostics (NASDAQ:LUCD), majority owned by PavMed (NASDAQ:PAVM), traded ~8% lower on Wednesday after the company said that a group of medical experts will meet in September ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results